Biohaven Ltd. short interest in 2025
In 2025, Biohaven Ltd.'s disclosed short interest ran from 9.83% of shares outstanding on 15 Jan 2025 to 18.89% on 31 Dec 2025, a change of +9.06 percentage points. The year's high was 18.89% on 31 Dec 2025 and its low 7.18% on 14 Mar 2025, averaging 10.73% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.69 days on 28 Feb 2025. Full history: Biohaven Ltd..
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 9.83% (15 Jan 2025)
- End of year
- 18.89% (31 Dec 2025)
- Change
- +9.06 pp
- High
- 18.89% (31 Dec 2025)
- Low
- 7.18% (14 Mar 2025)
- Average
- 10.73%
- Highest days to cover
- 11.69 (28 Feb 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 9.83% | 9.08 | |
| 31 Jan 2025 | 9.33% | 11.03 | |
| 14 Feb 2025 | 8.52% | 10.47 | |
| 28 Feb 2025 | 8.12% | 11.69 | |
| 14 Mar 2025 | 7.18% | 4.82 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 7.33% | 7.00 | |
| 15 Apr 2025 | 7.53% | 4.01 | |
| 30 Apr 2025 | 7.65% | 2.97 | |
| 15 May 2025 | 8.01% | 3.50 | 10-Q filed, results (8-K) |
| 30 May 2025 | 10.60% | 4.41 | |
| 13 Jun 2025 | 10.66% | 5.70 | |
| 30 Jun 2025 | 12.00% | 5.84 | |
| 15 Jul 2025 | 13.21% | 8.49 | |
| 31 Jul 2025 | 12.46% | 5.88 | |
| 15 Aug 2025 | 10.37% | 5.66 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 10.06% | 5.27 | |
| 15 Sep 2025 | 12.47% | 6.09 | |
| 30 Sep 2025 | 10.35% | 3.77 | |
| 15 Oct 2025 | 9.74% | 4.50 | |
| 31 Oct 2025 | 9.13% | 4.83 | |
| 14 Nov 2025 | 12.40% | 1.42 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 15.55% | 4.18 | |
| 15 Dec 2025 | 16.06% | 5.75 | |
| 31 Dec 2025 | 18.89% | 5.92 |
See also: Biohaven Ltd.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.